Amedisys/AMED

$91.60

0.39%
-
1D1W1MYTD1YMAX

About Amedisys

Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

Ticker

AMED

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Paul Kusserow

Employees

19,000

Headquarters

Baton rouge, United States

Amedisys Metrics

BasicAdvanced
$2.95B
Market cap
-
P/E ratio
-$0.31
EPS
0.84
Beta
-
Dividend rate
$2.95B
0.84226
$96.44
$73.10
284.57K
1.049
33.929
37.334
16,556.31
10.03%
-0.54%
-0.92%
-0.71%
1.321
2.769
23.725
0.59%
-108.48%
2.59%

What the Analysts think about Amedisys

Analyst Ratings

Majority rating from 12 analysts.
Hold

Price Targets

Average projection from 9 analysts.
6.75% upside
High $101.00
Low $73.00
$91.60
Current price
$97.78
Average price target

Amedisys Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
3.38% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$570.7M
2.61%
Net income
$19.3M
-25.48%
Profit margin
3.38%
-27.31%

Amedisys Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 8.89%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$1.00
$1.37
$0.98
$0.94
-
Expected
$0.88
$1.09
$1.08
$1.03
$1.02
Surprise
13.06%
25.49%
-9.17%
-8.89%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Amedisys stock?

Amedisys (AMED) has a market cap of $2.95B as of April 24, 2024.

What is the P/E ratio for Amedisys stock?

The price to earnings (P/E) ratio for Amedisys (AMED) stock is 0 as of April 24, 2024.

Does Amedisys stock pay dividends?

No, Amedisys (AMED) stock does not pay dividends to its shareholders as of April 24, 2024.

When is the next Amedisys dividend payment date?

Amedisys (AMED) stock does not pay dividends to its shareholders.

What is the beta indicator for Amedisys?

Amedisys (AMED) has a beta rating of 0.84. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Amedisys stock price target?

The target price for Amedisys (AMED) stock is $97.78, which is 7.26% above the current price of $91.16. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Amedisys stock

Buy or sell Amedisys stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing